Our Research

Our Research

>> Research Departments
>> Find Clinical Trials
>> Our Publications
>> Our Research Collaborations


Contact Details

  Street address:
Level 11, KGV Building
Missenden Road
CAMPERDOWN NSW 2050
 
Postal address:
Post Office Box M30
Missenden Road NSW 2050

Phone: (02) 9515-6111
Fax: (02) 9515-9610

Online Feedback
Patients in Research

The Haematology Clinical Trials Unit at Concord Cancer Centre supports the hopes for cure for patients with blood cancers. Watch the incredible stories of our brave patients.

Haematology Clinical Trials @ Concord Hospital
Haematology Department
Haematology Department

Haematology Department

Our Research

The Concord Haematology Department delivers world-class tertiary Haematology clinical care, supported by active clinical, translational and basic research. The Department has eight haematologists led by Head of Department A/Professor Ilona Cunningham. Basic and translational research projects within Concord Haematology include platelet biology, thrombosis in cancer, therapeutic AML antibody development and DNA methylation in CLL, lymphoma and myeloma. Clinical and epidemiological research projects include patient-reported outcomes research, cancer survivorship, patterns of care research in myeloma and lymphoma and the development of a novel web-based patient-led data collection tool in Waldenstrom's macroglobulinaemia.

The Concord Clinical Research Unit (CRU) maintains a diverse portfolio of quality trials to provide access to emerging therapies and maintain clinical practice within an environment of evidence-based medicine. The CRU hosts a broad portfolio of trials in malignant and non-malignant haematology, with on average 30 actively recruiting trials including early phase Ib/II trials and investigator-initiated trials. As such, it has the largest portfolio of haematology clinical trials in NSW.

Key Achievements

  • A/Prof Trotman continues her collaborations with LYSARC (The Lymphoma Academic Research Organisation - France) and FIL (Italian Lymphoma Group) to set create international guidelines for PET scanning in follicular lymphoma. On the strength of her data on PET in indolent lymphoma A/Prof Trotman applied for (MSAC Application 1406) and obtained approval in Dec 2016 for an MBS listing for PET scanning for indolent lymphoma, anticipated listing Nov 2017. She continues her roles on the Scientific Advisory Board of the Australasian Leukaemia and Lymphoma Group, in the High Grade and Low Grade Lymphoma Disease Groups, and as Chair of the Low Grade Lymphoma Group.
  • Ongoing success with ClinTrial Refer Haematology which has been associated with an instant and sustained 9-fold increase in patient cross-referrals for trials across NSW/ACT in the past 3 years and 16 derivative Apps for other cancer trials portfolios have been created.
  • The financial independence of the Clinical Research Unit continues to be supported by a dedicated fundraising team with a flagship biannual event 'A Bloody Great Night Out'. www.abloodygreatnightout.com.au
  • In 2016 A/Prof Trotman, together with her advanced trainee Dr Ibrahim Tohidi-Esfahani, also initiated an international observational study, WhiMSICAL, which collects patient-derived clinical data on the rare lymphoma Waldenstrom's Macroglobulinemia via www.cart-wheel.org. This innovative patient-clinician collaborative study has already had early data presented at national and international conferences.
  • A/Prof Cunningham continues to be involved in the HealthPathways Research and Evaluation Committee together with the Menzies Research Institute whose aim is to analyse the implementation and delivery of a web-based referral system to connect general practitioners with local specialists.
  • Dr Chen has developed and continues to strengthen international and national collaborations with: 1. University of Cambridge Cell Function Team, Department of Haematology, 'Procoagulant platelets in acute coronary syndrome and ischaemic stroke.' Genomics of platelet function in health and disease. 2. Singapore General Hospital Professor Lai Heng Lee, Singapore General Hospital,'Procoagulant platelets as predictors of thrombosis in myeloproliferative disease.' 3. Ongoing exchange of clinical, basic and translational research in myeloproliferative disorders. 4. Australian Red Cross Blood Service Dr Denese Marks and Dr Lacey Johnston, Development and Storage Research Group
  • Dr Gasiorowski submitted his PhD thesis 'CD300f as a novel therapeutic target in AML' and continues his collaboration with the ANZAC Research Institute.

Awards/Medals

  • Royal College of Pathologists Australasia pathology research scholarship awarded to medical student of Dr Chen (Samuel Wang)
  • 2016 A/Prof Trotman was awarded Drummoyne Woman of the Year 2016 for her community engagement in the promotion of clinical trials, and continues role as inventor of ClinTrial Refer: a smart-phone App that helps doctors & patients connect rapidly with available trials through current comprehensive listings.
  • Dr Chen was awarded Drummoyne Woman of the Year 2017 for her contribution to the interface between basic translational research at the ANZAC Research Institute and clinical care at Concord Hospital.

Research Staff

Haematologists

  • A/Prof Ilona Cunningham - Head of Department
  • A/Prof Judith Trotman - Clinical Research Unit Director
  • Dr Alessandra Bianchi - Haematologist
  • Dr Jane Estell - Haematologist
  • Dr Emma Verner - Haematologist
  • Dr Vivien Chen - Haematologist
  • Dr Robin Gasiorowski - Haematologist
  • Dr Nicole Wong Doo - Haematologist
  •  

Clinical Research Unit (CRU)

  • Mr Admir Huseincehajic, BSc - CRU Manager
  • Dr Yiu Lam Kwan, MBBS, FRACP, FRCPA- Manager, Clinical Research Strategy
  • Dr Janlyn Falconer, B Sci (Medicine) MBBS FRACP FRCPA - Clinical Trial Research Fellow
  • Ms Jennifer DeVos, RN
  • Ms Sylvia Chan, RN
  • Mr Kumar Sarandar, MD, MPH
  • Ms Jung-Ah Lee, RN
  • Mr Salman Momin, MPharm

Higher Degree Students:

Dr Chen:
Post-doctoral fellows

  • Dr Helena Liang
  • Dr Morgane Bourcy

PhD students:

  • Dr Ibrahim Tohidi
  • Mr Geoffry Kershaw


Publications and Presentations

Publication Details:
  1. Caroline, J. Reddel, J. Allen, A. Ryland, T. Chen, V. Curnow, J. Kritharides, L. Robertson, G. Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent. Journal of Thrombosis and Haemostasis. 2017 DOI: 10.1111/jth.13612.
  2. Oberoi, D. White, V. Seymour, J. Prince, H. Harrison, S. Jefford, M. Winship, I. Hill, D. Bolton, D. Kay, A. Millar, J. Wong Doo, N. Giles, G. The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period. J Cancer Surviv. 2017 Jan 31. doi: 10.1007/s11764-016-0591-y
  3. Nanni, C. Cottereau, A. Lopci, E. Bodet-Milin, C. Coronado, M. Pro, B. Kim, W. Trotman, J. Barrington, S. Duhrsen, U. Vander Borght, T. Zamagni, E. Bodéré, F. Messiou, C. Rahmouni, A. Buvat, I. Andre, M. Hertzberg, M. Oyen, W. Casasnovas, O. Luminari, S. Garderet, L. Montravers, F. Versari, A. Zucca, E. Moreau, P. Cheson, B. Haioun, C. Gallamini, A. Meignan, M. Report of the 6th international workshop on PET scan in lymphoma and myeloma. Leukaemia and Lymphoma. 2017 Mar 7:1-6
  4. Talaulikar, D. Tam, C. Joshua, D. Ho, J. Szer, J. Quach, H. Spencer, A. Harrison, S. Mollee, P. Roberts, A. Horvath, N. Lee, C. Zannettino, A. Brown, R. Augustson, B. Jaksic, W. Gibson, J. Kalff, A. Johnston, A. Trotman, J. Kalro, A. Grigoriadis, G. Ward, C. Prince, H. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Intern Med J. 2017 Jan;47(1):35-49
  5. Federico, M. Trotman, J. Dreyling, M. Time to publish: challenging the performance of cooperative group lymphoma trials. The Lancet Haematology 2016 4 (1) e8-e10
  6. Hertzberg, M. Taper, J. Trotman, J. Gill, D. Ho, S. Cull, G. Fay, K. Chong, G. Grigg, A. Lewis, I. Milliken, S. Renwick, W. Hahn, U. Filshie, R. Watson, A. Kannourakis, G. Wolf, M. Warburton, P. Larsen, S. Gandhi, M. Seymour, J. Hicks, R. Early Treatment Intensification with R-ICE Chemotherapy Followed by Autologous Stem Cell Transplantation Using Zevalin-BEAM for Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma as Identified by Interim PET/CT Scan Performed After Four Cycles of R-CHOP-14 Chemotherapy: A multicentre phase II study of the Australasian Leukaemia Lymphoma Study Group (ALLG). epub Nov Haematologica 2016
  7. Trotman, J. Trinh, J. Kwan, Y. Estell, J. Fletcher, J. Archer, K. Lee, K. Foo, K. Curnow, J. Bianchi, A. Wignall, L. Verner, E. Gasiorowski, R. Siedlecka, E. Cunningham, I. Formalising multidisciplinary peer review: developing a haematological malignancy specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence based clinical practice. Intern Med J. 2016 Oct 18.
  8. Meignan, M. Cottereau, A. Versari, A. Loïc. Dupuis, J. Boussetta, S. Grassi, I. Casasnovas, R. Haioun, C. Tilly, H. Tarantino, V. Dubreuil, J. Federico, M. Salles, G. Luminari, S. Trotman, J. Baseline Metabolic Tumor Volume predicts outcome in high tumor burden follicular lymphoma: a pooled analysis of three multicenter studies. Journal of Clinical Oncology 2016 34, no. 30 3618-3626.
  9. Trotman, J. Nath, C. Nivison-Smith, I. Gurney, H. Zeng, L. Kwan, Y. Presgrave, P. Tiley, C. Joshua, D. Kerridge, I. Earl, J. Shaw, P. Exposure to High Dose Melphalan correlates with Overall Survival in patients undergoing autologous transplantation for myeloma. Br J Clin Pharmacol. 2016 Jul;82(1):149-59
  10. Clark, G. Kupresanin, F. Fromm, P. Ju, X. Muusers, L. Silveira, P. Elgundi, Z. Gasiorowski, R. Papadimitrious, M. Bryant, C. Lee, K. Clarke, C. Young, J. Chan, A. Harman, A. Botting, R. Cabezón, R. Benitez-Ribas, D. Brooks, A. Dunbar, P. Hart, D. New Insights into the Phenotype of Human Dendritic Cell Populations. Clin Transl Immunology. 2016 Jan 29;5(1):e61.
  11. Pasalic, L. Pennings, G. Campbell, H. Connor, D. Kritharides, L. Chen, V. (2016). Flow-Cytometric Analysis of Platelet-Membrane Glycoprotein Expression and Platelet Activation. Methods in Molecular Biology, Platelets and Megakaryocytes. Accepted 2016
  12. Thoms, J. Knezevic, K. Liu, J. Glaros, E. Thai, T. Qiao, Q. Campbell, H. Packham, D. Huang, Y. Papathanasiou, P. et al.. Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in DHFR. Molecular and cellular biology. 2016 36(8): 1222-1236.
  13. Wong, C. Ng, A. Lau, J. Chow, V. Chen, V. Yong, A. Sindone, A. Marwick, T. Kritharides, L. High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy. Thrombosis and haemostasis 2016 115(6): 1191-1199.
  14. Abed, H. VM, C. Kilborn, M. Sy, R. Peri-procedural Management of Novel Oral Anticoagulants During Atrial Fibrillation Ablation: Controversies and Review of the Current Evidence. Heart, Lung and Circulation. 2016
  15. Liou, K. Jepson, N. Buckley, N. Chen, V. Thomas, S. Russell, E. Ooi, S. Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial. Cardiovascular Drugs and Therapy, 2016 30(2): 169-175.
  16. Pasalic, L. Williams, R. Siupa, A. Campbell, H. Henderson, M. Chen, V. Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis. Nanomedicine : nanotechnology, biology, and medicine. 2016 12(4): 977-986.
  17. Pasalic, L. Wang, S. Chen, V. Platelets as Biomarkers of Cardiovascular Disease. Seminars in Thrombosis and Haemostasis. 2016 42 (3) 223-33
  18. Schulman, S. Bendapudi, P. Sharda, A. Chen, V. Bellido-Martin, L. Jasuja, R. Furie, B. Flaumenhaft, R. Furie, B. Extracellular Thiol Isomerases and Their Role in Thrombus Formation. Antioxidants & redox signaling 2016 24, 1-15.
  19. Johnson, P. Federico, M. Kirkwood, A. Fossa, A. Berkahn, L. Carella, A. d'Amore, F. Enblad, G. Franceschetto, A. Fulham, M. Luminari, S. O'Doherty, M. Patrick, P. Roberts, T. Sidra, G. Stevens, L. Smith, P. Trotman, J. Viney, Z. Radford, J. Barrington, S. Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma NEJM, 23 June 2016; 374:25;2419-2429.
  20. Barrington, S. Kirkwood, A. Franceschetto, A. Fulham, M. Roberts, T. Almquist, H. Brun, E. Hjorthaug, K. Viney, Z. Pike, L. Federico, M. Luminari, S. Radford, J. Trotman, J. Fosså, A. Berkahn, L. Molin, D. D'Amor, F. Sinclair, D. Smith, P. O'Doherty, M. Stevens, L. Johnson, P. PET-CT for Staging & Early Response: Results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) Blood, 2016 Online January 10.
  21. Wong Doo, N. Joo, J. Vajdic, C. Schmidt, D. Wong, E. Jung, C. Severi, G. Park, D. Chung, J. Laura, B. Prince, H. Seymour, J. Tam, C. Hopper, J. English, D. Milne, R. Harrison, S. Southey, M. Giles, G. Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature b cell neoplasms. Epigenomics 2016 Jan;8(1):55-66
  22. Clark, G. Kupresanin, F. Fromm, P. Ju, X. Muusers, L. Silveira, P. Elgundi, Z. Gasiorowski, R. Papadimitrious, M. Bryant, C. Lee, K. Clarke, C. Young, J. Chan, A. Harman, A. Botting, R. Cabezón, R. Benitez-Ribas, D. Brooks, A. Dunbar, P. Hart, D. New Insights into the Phenotype of Human Dendritic Cell Populations. Clin Transl Immunology. 2016 Jan 29;5(1):e61.
  23. Pasalic, L. Williams, R. Siupa, A. Campbell, H. Henderson, M. Chen, V. Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis. Nanomedicine : nanotechnology, biology, and medicine. 2016 12(4): 977-986.
  24. Bachy, E. Estell, J. Van de Neste, E. Bouabdallah, R. Bargay, J. Delmer, A. Gelas-Dore, B. Gomes da Silva, M. Fitoussi, O. Belada, D. Maisonneuve, H. Intragumtornchai, T. Lamy, T. Dartigues, P. Seymour, J. Salles, G. Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study. American Journal of Hematology 2016 Jun; 9(4):410-5
  25. Quach, H. Harrison, S. Fernyhough, L. Henderson, R. Corbett, G. Baker, B. Browett, P. Blacklock, H. Forsyth, C. Underhill, C. Cannell, P. Trotman, J. Neylon, A. Link, E. Cowan, L. Li, J. Dimopoulos, M. Prince, H. Lower Dose Lenalidomide and dexamethasone for Patients with Relapsed/Refractory multiple myeloma who are aged ≥60 years and/or at risk of myelosuppression: Final Results of the RevLite trial and Matched Comparison to the MM009 and MM010 trials. British Journal of Haematology-2016-01648

Presentations:
  1. Tohidi, I. Tan, S. Johnstone, L. Marks, D. Chen, V. Identification of procoagulant platelets subsets in cold-stored and cryopreserved platelets using a novel cell death marker. International Society of Blood Transfusion, Copenhagen 2017.
  2. Pasalic, L. Lau, J. Pennings, G. Campbell, H. Kritharides, L. Chen, V. Patients with coronary artery disease have a pathological P2Y12 platelet response with heightened procoagulant platelet potential. International Society Thrombosis and Haemostasis Berlin 2017
  3. Wang, S. Pennings, G. Campbell, H. Chen, V. Anticoagulants Differentially Affect Procoagulant Platelet Formation. International Society Thrombosis and Haemostasis Berlin 2017
  4. Wang, S. Bourcy, M. Chen, V. Heparin Decreases Thrombin Induced Procoagulant Platelet Formation via a Direct Platelet Effect. International Society Thrombosis and Haemostasis Berlin 2017
  5. Vardy, J. Tan, C. Turner, J. Kerin-Ayres, K. Deguchi, C. Khatri, S. Butler, S. Wignall, L. Cunningham, I. Malalasekera, A. Dhillon, H. Physical and psychological health status of cancer survivors following primary adjuvant treatment. Flinders Survivorshiop Centre 2017
  6. Wong Doo, N. Makalic, E. Schmidt, D. Joo, J. Jung, C. Giles, G. A distinct DNA methylation signature is detectable in peripheral blood years before diagnosis with MBCN, Poster at American Society of Hematology, Annual Scientific meeting, Dec 2016
  7. Salles, G. Trotman, J. Lill, M. Cheson, B. Schuster, S. Hou, J. Radford, J. Spencer, A. Gartenberg, G. Vermeulen, J. Balasubramanian, S. Deshpande, S. Caballero, D.. Pseudo-progression among patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. American Society of Hematology, Annual Scientific meeting, Dec 2016
  8. Cottereau, A. Versari, A. Chartier, L. Dupuis, J. Tarantino, V. Casasnovas, O. Tilly, H. Haioun, C. Federico, M. Salles, G. Luminari, S. Meignan, M. Trotman, J. Low SUVmax measured on baseline FDG-PET/CT and elevated β2 microglobulin are negative predictors of outcome in high tumor burden follicular lymphoma: a pooled analysis of three prospective studies Oral presentation American Society of Haematology Annual Scientific Meeting Dec 4 2016
  9. Tohidi-Esfahani, I. Warden, A. DeNardis, P. Tam, C. Scott, C. Trotman, J. WhiMSICAL (Waldenström's Macroglobulinemia Study Involving CArt-wheeL): empowering patients internationally to contribute patient-derived data for observational research. HAA, Melbourne 2016
  10. Tohidi-Esfahani, I. Warden, A. DeNardis, P. Tam, C. Scott, C. Trotman, J. WhiMSICAL (Waldenström's Macroglobulinemia Study Involving CArt-wheeL): empowering patients internationally to contribute patient-derived data for observational research. International Waldenstroms Macroglobulinaemia Workshop, Amsterdam, Oct 6 2016
  11. Bradstock, K, Link, E. Di Iulio, J. Szer, J. Marlton, P. Wei, A. Enno, A. Schwarer, A. Lewis, I. D'Rozario, J. Coyle, L. Cull, G. Campbell, P. Leahy, M. Hahn, U. Cannell, P. Tiley, C. Lowenthal, R. Moore, J. Cartwright, K. Cunningham, I. Taper, J. Grigg, A. Roberts, A. Benson, W. Hertzberg, M. Deveridge, S. Rowlings, P. Mills, A. Gill, D. Bardy, P. Campbell, L. Seymour, J. Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival. Oral presentation American Society of Haematology Annual Scientific Meeting Dec 4 2016
  12. Vardy, J, Tan, C. Turner, J. Butler, S. Deguchi, C. Khatri, S. Cunningham, I. Wignall, L. Stefanic, N. Kerin-Ayres, K. Warby, A. Malalasekera, A. Dhillon, H. Quality of life, symptoms, physical activity and body mass index of cancer survivors attending the Sydney Survivorship Clinic . Multinational Association of supportive Care in Cancer Conference 2016
  13. Clark, G. Gasiorowski, R. Fromm, P. Bradstock, K. Hart, D. Therapeutic Antibodies Targeting Acute Myeloid Leukaemia. Sydney Cancer Conference. September 2016.
  14. Campbell, A. Powell, M. Gasiorowski, R. The use of Flow Cytometry in the Diagnosis of Low Grade Myelodysplasia. ACS 2016. October 2016
  15. Campbell, A. Powell, M. Gasiorowski, R. The use of Flow Cytometry in the Diagnosis of Low Grade Myelodysplasia. HAA 2016. November 2016.
  16. Clark, G. Gasiorowski, R. Kupresanin, F. Mekkawy, A. Hart, D. Understanding the biology of the CD300f inhibitory receptor as a target for anti-AML antibodies. International Congress of Immunology. August 2016.
  17. Clark, G. Gasiorowski, R. Fromm, P. Bradstock, K. Hart, D. CD300f Epitopes in Acute Myeloid Leukaemia. New Directions in Leukaemia Research. March 2016.
  18. Hsu, J. Bryant, C. Fromm, P. Papadimitrious, M. Orellana, D. Suen, H. Yang, S. Weatherburn, C. Gasiorowski, R. Iland, H. Brown, R. Joshua, D. Ho, P. Gibson, J. Clark, G. Hart, D. A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia. ASH December 2016.
  19. Trotman, J. Shaw, P. Tiley, C. Ramanathan, S. Grigg, A. Larsen, S. Presgrave, P. Kwan, Y. Newman, E. Estell, J. Nath, C. Evaluation of Pharmacokinetic-based dose predictions of high dose melphalan in patients with multiple myeloma, Australian Myeloma Meeting, 2016.
  20. Mateos, M. Estell, J. Barreto, W. Corradini, P. Min, C. Medvedova, E. Qi, M. Schecter, J. Amin, H. Qin, X. Deraedt, W. Casneuf, T. Chiu, C. Sasser, K. Nooka, A. Efficacy of Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Myeloma Based on Prior Lines of Therapy: Updated Analysis of Castor, Oral Presentation at American Society of Hematology, Annual Scientific meeting, Dec 2016
  21. Wong Doo, N. White, V. Milne, R. Prince, H. Harrison, S. Giles, G. on behalf of the IMPROVE project. Early autologous stem cell transplant associated with improved overall survival in multiple myeloma: findings from a population based study, Oral presentation at HAA Annual Scientific Meeting, 2016
  22. Dimopoulos, M. Trotman, J. Tedeschi, A. Matous, J. Macdonald, D. Tam, C. Tournilhac, O. Ma, S. Oriol, A. Heffner, L. Shustik, C. García-Sanz, R. Cornell, R. Fernández de Larrea, C. Castillo, J. Granell, M. Kyrtsonis, M. Leblond, V. Symeonidis, A. Singh, P. Li, J. Graef, T. Bilotti, E. Treon, S. Buske, C. on behalf of the iNNOVATE Study Group. Single-Agent Ibrutinib in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Updated Results From a Multicenter, Open-Label Phase 3 Substudy (iNNOVATE) EHA, June 2016
  23. Trotman, J. Matous, J. Ma, S. Heffner, L. Cornell, R. Castillo, J. Treon, S. Graef, T. Buske, C. Dimopoulos, M. on behalf of the iNNOVATE study group. Single-agent Ibrutinib in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia (WM): Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATE) Int Congress Haem Malignancies 2016
  24. Pasalic, L. Hogg, P. Chen, V. A novel marker for procoagulant platelets demonstrates coronary artery disease patients have a heightened procoagulant response. Platelets 2016 International Symposium, Boston, 2016.
  25. Lau, J. Pennings, G. Reddel, C. Campbell, H. Chen, V. Yong, A. Kritharides, L. Remote Ischaemic Preconditioning Exerts Pathway-Specific Inhibition of Platelet Activation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy. European Society of Cardiology Congress, Florence, 2016
  26. Wang, S. Campell, H. Chen, V. Effect of anticoagulants on procoagulant platelet formation. HAA, Melbourne 2016
  27. Biscoe, A. Taulihaur, D. Chen, V. MYD88 mutation homology and IgHv sequencing differentiates large cell transformation of Waldenstroms Macroglobulinaemia from de novo large cell lymphoma. 2016

Research Grants

GRANTING BODY AWARDEES PROJECT TITLE YEARS total $$ Years
SLHD Vivien Chen Annual Health Research Infrastructure Award  $ 10,000.00 2016
Cancer Institute Vivien Chen (CIB), Derek Hart ("CIA) Equipment Grant: Image Intensified Fluorescent Intravital Microscope  $ 412,000.00 2016
Australian Society of Thrombosis and Haemostasis Clinical Trials Group Vivien Chen Anticoagulation in Cancer Associated Thrombosis Phase II trial  $ 80,000.00 2016-2017
Tour de Cure Vivien Chen Cancer project  $ 10,000.00 2016

Contact details for department

Head of Department: A/Prof Ilona Cunningham

Department/Unit: Haematology Department
Address:
Concord Hospital
Hospital Road
Concord NSW 2139
Telephone: 02 9767 6648
Facsimile: 02 9767 7650
Web: http://www.slhd.nsw.gov.au/concord/departments.html
Email: nicole.wongdoo@health.nsw.gov.au